Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197417 · ClinicalTrials.gov registry record · Phase 2
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 208
- Enrollment target
NCT01197417 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 208 participants.
The verdict
NCT01197417, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 208 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of intravenous magnesium in shortening the duration of a pain crisis and to determine the health-related quality of life and short term outcomes of children treated with intravenous magnesium during an acute pain crisis.
Interventions
- DRUG Normal Saline Placebo
- DRUG Intravenous Magnesium Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01197417
The ClinicalTrials.gov registry entry for NCT01197417 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline Placebo is the first listed.
NCT01197417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01197417 about?
NCT01197417 is a clinical study titled "Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis". The purpose of this study is to determine the safety and efficacy of intravenous magnesium in shortening the duration of a pain crisis and to determine the health-related quality of life and short term outcomes of children treated with intravenous magnesium during an acute pain crisis.
What is the current status of trial NCT01197417?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 208 participants. The study started on 2010-12. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01197417?
The interventions under investigation include: Normal Saline Placebo (DRUG), Intravenous Magnesium Sulfate (DRUG).
Who is sponsoring clinical trial NCT01197417?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.